1. Home
  2. PROV vs STRO Comparison

PROV vs STRO Comparison

Compare PROV & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$15.38

Market Cap

98.1M

Sector

Finance

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$8.66

Market Cap

94.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
STRO
Founded
1956
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.1M
94.9M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
PROV
STRO
Price
$15.38
$8.66
Analyst Decision
Hold
Hold
Analyst Count
2
7
Target Price
$16.25
$19.67
AVG Volume (30 Days)
5.9K
99.8K
Earning Date
10-28-2025
11-06-2025
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$39,823,000.00
$105,646,000.00
Revenue This Year
$4.14
$62.61
Revenue Next Year
$3.70
N/A
P/E Ratio
$17.06
N/A
Revenue Growth
0.07
N/A
52 Week Low
$12.98
$5.23
52 Week High
$16.70
$30.10

Technical Indicators

Market Signals
Indicator
PROV
STRO
Relative Strength Index (RSI) 47.02 88.27
Support Level $15.01 $0.72
Resistance Level $15.65 $9.38
Average True Range (ATR) 0.41 0.38
MACD 0.03 0.95
Stochastic Oscillator 34.07 92.10

Price Performance

Historical Comparison
PROV
STRO

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: